1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Study of AK104 Plus Lenvatinib and TACE in HCCUnresectable, Non-metastatic Hepatocellular CarcinomaActive, not recruitingPhase 22025-03-12NCT05319431